Condition
Acute Copd Exacerbation
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06538376Not ApplicableRecruiting
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
NCT05854901Not ApplicableUnknown
PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations
NCT05497986Not ApplicableUnknown
Conventional Low Flow Oxygenation Versus High Flow Nasal Cannula in Hypercapnic Respiratory Failure
Showing all 3 trials